Henry Schein Reports Record Second-Quarter 2021 Financial Results From Continuing Operations

Go back to Henry Schein Reports Record Second-Quarter 2021 Financial Results From Continuing Operations

Henry Schein (HSIC) PT Raised to $92 at Baird

August 4, 2021 8:59 AM EDT

Baird analyst Jeff Johnson raised the price target on Henry Schein (NASDAQ: HSIC) to $92.00 (from $90.00) while maintaining an Outperform rating.

The analyst commented, "End market improvements continued in 2Q (especially for dental) and HSIC continues to execute well, highlighted by above-company... More

Henry Schein (HSIC) Tops Q2 EPS by 14c

August 3, 2021 6:37 AM EDT

Henry Schein (NASDAQ: HSIC) reported Q2 EPS of $1.11, $0.14 better than the analyst estimate of $0.97. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.89 billion.

GUIDANCE:

Henry Schein sees FY2021 EPS of at least $3.85, versus the consensus... More